We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
RUFY3
  • TISSUE

  • premium

    CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

RUFY3

Gene description

RUN and FYVE domain containing 3

Protein class

Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

7
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Expressed in all
HPA (normal tissue):Expressed in all

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Cytoplasmic expression in most tissues, high abundance in CNS and testis.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data. Pending external verification.

Reliability score

Approved based on 2 antibodies.
HPA022952 , HPA022970
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in pancreatic cancer (favourable), head and neck cancer (favourable) and liver cancer (unfavourable).
0.00.10.20.30.40.50.60.70.80.91.0 0 1 2 3 4 5 6 7 Pancreatic cancer p<0.001
0.00.10.20.30.40.50.60.70.80.91.0 0 1 2 3 4 5 6 7 8 91011121314151617 Head and neck cancer p<0.001
0.00.10.20.30.40.50.60.70.80.91.0 0 1 2 3 4 5 6 7 8 910 Liver cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all
0.05.0101520253035FPKMBreast cancer (BRCA)Cervical cancer (CESC)Colorectal cancer (COAD,READ)Endometrial cancer (UCEC)Glioma (GBM)Head and neck cancer (HNSC)Liver cancer (LIHC)Lung cancer (LUAD,LUSC)Melanoma (SKCM)Ovarian cancer (OV)Pancreatic cancer (PAAD)Prostate cancer (PRAD)Renal cancer (KICH,KIRC,KIRP)Stomach cancer (STAD)Testis cancer (TGCT)Thyroid cancer (THCA)Urothelial cancer (BLCA)

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA022952
HPA022970

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Moderate to strong cytoplasmic positivity was observed in several cases of glioma, renal and liver cancers. Remaining cancer tissues were weakly stained or negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Strong nuclear staining was displayed in a subset of cases of mucinous ovarian cancer, urothelial cancer and adenocarcinoma in stomach, pancreas and lung. Moderate cytoplasmic staining, often with additional membranous or nuclear membranous positivity, was observed in all cancer types.

GENE INFORMATION

Gene name

RUFY3 (HGNC Symbol)

Synonyms

KIAA0871, RIPx, Singar1, ZFYVE30

Description

RUN and FYVE domain containing 3 (HGNC Symbol)

Entrez gene summary

Chromosome

4

Cytoband

q13.3

Chromosome location (bp)

70704204 - 70807315

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000018189 (version 83.38)

Entrez gene

22902

UniProt

Q7L099 (UniProt - Evidence at protein level)

neXtProt

NX_Q7L099

Antibodypedia

RUFY3 antibodies

PROTEIN BROWSER

RUFY3-001
RUFY3-002
RUFY3-003
RUFY3-004
RUFY3-005
RUFY3-007
RUFY3-008

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

RUFY3-001
ENSP00000226328
ENST00000226328
Q7L099 [Direct mapping]
Protein RUFY3
A0A024RDD7 [Target identity:100%; Query identity:100%]
RUN and FYVE domain containing 3, isoform CRA_a
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0007015 [actin filament organization]
GO:0012505 [endomembrane system]
GO:0016020 [membrane]
GO:0030027 [lamellipodium]
GO:0030054 [cell junction]
GO:0030175 [filopodium]
GO:0030335 [positive regulation of cell migration]
GO:0030424 [axon]
GO:0030425 [dendrite]
GO:0030426 [growth cone]
GO:0043204 [perikaryon]
GO:0045773 [positive regulation of axon extension]
GO:0050771 [negative regulation of axonogenesis]
GO:0071437 [invadopodium]
GO:0090316 [positive regulation of intracellular protein transport]
GO:2000114 [regulation of establishment of cell polarity]
Show all
469 aa
53 kDa
No 0
RUFY3-002
ENSP00000370394
ENST00000381006
Q7L099 [Direct mapping]
Protein RUFY3
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0007015 [actin filament organization]
GO:0012505 [endomembrane system]
GO:0016020 [membrane]
GO:0030027 [lamellipodium]
GO:0030054 [cell junction]
GO:0030175 [filopodium]
GO:0030335 [positive regulation of cell migration]
GO:0030424 [axon]
GO:0030425 [dendrite]
GO:0030426 [growth cone]
GO:0043025 [neuronal cell body]
GO:0043204 [perikaryon]
GO:0045773 [positive regulation of axon extension]
GO:0046872 [metal ion binding]
GO:0050770 [regulation of axonogenesis]
GO:0050771 [negative regulation of axonogenesis]
GO:0050772 [positive regulation of axonogenesis]
GO:0071437 [invadopodium]
GO:0090316 [positive regulation of intracellular protein transport]
GO:2000114 [regulation of establishment of cell polarity]
Show all
620 aa
70.6 kDa
No 0
RUFY3-003
ENSP00000425400
ENST00000502653
Q7L099 [Direct mapping]
Protein RUFY3
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0007015 [actin filament organization]
GO:0012505 [endomembrane system]
GO:0016020 [membrane]
GO:0030027 [lamellipodium]
GO:0030054 [cell junction]
GO:0030175 [filopodium]
GO:0030335 [positive regulation of cell migration]
GO:0030424 [axon]
GO:0030425 [dendrite]
GO:0030426 [growth cone]
GO:0043204 [perikaryon]
GO:0045773 [positive regulation of axon extension]
GO:0046872 [metal ion binding]
GO:0050771 [negative regulation of axonogenesis]
GO:0071437 [invadopodium]
GO:0090316 [positive regulation of intracellular protein transport]
GO:2000114 [regulation of establishment of cell polarity]
Show all
567 aa
64.7 kDa
No 0
RUFY3-004
ENSP00000425574
ENST00000513597
D6RCQ1 [Direct mapping]
Protein RUFY3
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
201 aa
22.2 kDa
No 0
RUFY3-005
ENSP00000399771
ENST00000417478
Q7L099 [Direct mapping]
Protein RUFY3
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0007015 [actin filament organization]
GO:0012505 [endomembrane system]
GO:0016020 [membrane]
GO:0030027 [lamellipodium]
GO:0030054 [cell junction]
GO:0030175 [filopodium]
GO:0030335 [positive regulation of cell migration]
GO:0030424 [axon]
GO:0030425 [dendrite]
GO:0030426 [growth cone]
GO:0043204 [perikaryon]
GO:0045773 [positive regulation of axon extension]
GO:0050771 [negative regulation of axonogenesis]
GO:0071437 [invadopodium]
GO:0090316 [positive regulation of intracellular protein transport]
GO:2000114 [regulation of establishment of cell polarity]
Show all
506 aa
55.9 kDa
No 0
RUFY3-007
ENSP00000426734
ENST00000503876
D6REM9 [Direct mapping]
Protein RUFY3
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
155 aa
17.3 kDa
No 0
RUFY3-008
ENSP00000426165
ENST00000514898
D6RH24 [Direct mapping]
Protein RUFY3
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
98 aa
10 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.